Skip to main content
SpringerLink
Log in

Traitements symptomatiques des douleurs des métastases vertébrales

  • Chapter
Métastases vertébrales

  • 367 Accesses

Abstrait

Les métastases osseuses constituent la cause la plus fréquente de douleurs chez les patients atteints de cancer (20).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Ambrus JL, Hoffman M, Abrus CM et al. (1992) Prevention and treatment of osteoporosis. One of the most frequent disorders in American women: a review. J Med 23: 369–88

    PubMed  CAS  Google Scholar 

  2. Ashby M (1993) Radiotherapy in the palliation of cancer. In: Patt RB (ed) Cancer pain, JB Lippincott Company, p 235

    Google Scholar 

  3. Avellasona AM, West CR (1982) Experience with transcutaneous electrical nerve stimulation for relief of intractable pain in cancer patients. J Med 13: 202–13

    Google Scholar 

  4. Berenson JR, Lichtenstein A, Porter L et al. (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334: 488–93

    Article  PubMed  CAS  Google Scholar 

  5. Blomquist C, Elomaa I, Porkha L, Laronen SL, Lamberg-Allard T (1988) Evaluation of salmon calcitonine treatment in bone metastases from breast cancer. A controlled trial. Bone 9: 45–51

    Article  Google Scholar 

  6. Body JJ, Lichinister MR, Diehl I, Schlosser K et al. (1999) Double-blind placebo-controlled trial of intravenous ibandronate in breast cancer metastatic to bone. Proc ASCO 18: 575a (abs 2222)

    Google Scholar 

  7. Bonica JJ, Ventafridda V, Twycross RG (1990) The management of pain (2nd edition), Malvern, Lea & Febiger, p 400–60

    Google Scholar 

  8. Bruera E, Roca E, Cedaro L, Carraco S, Chacon R (1985) Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69: 751–4

    PubMed  CAS  Google Scholar 

  9. Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327: 614–9

    Article  PubMed  CAS  Google Scholar 

  10. Cherny NI, Portenoy KP (1994) Practical issues in the management of cancer pain. In: Textbook of pain (3rd edition), Wall Melzack, Churchill Livingstone, p 1437

    Google Scholar 

  11. Cherny NI, Portenoy RK (1994) Cancer pain: principles of assessment and syndromes. In: Textbook of pain (3rd edition), Wall Melzack, Churchill Livingstone, p 787

    Google Scholar 

  12. Clinical Practice Guideline (1994) Management of Cancer Pain. Number 9, mars 1994

    Google Scholar 

  13. Dooley M, Balfour JA (1999) Ibandronate. Drugs 57: 101–8

    Article  PubMed  CAS  Google Scholar 

  14. Eisenberg LE, Barker CS, Carr DB, Mosteller F, Chalmers TC (1994) Efficacy and safety of nonsteroidal anti-inflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 12: 2756–65

    PubMed  CAS  Google Scholar 

  15. Ernst DS, Mac Donald RN, Paterson AHG, Jensen J, Brasher P, Bruera E (1992) A double blind cross over trial of IV clodronate in metastatic bone pain. J Pain Symptom Management 7: 4–11

    Google Scholar 

  16. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D (1990) A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47: 720–5

    PubMed  CAS  Google Scholar 

  17. Ferreira SH, Nakamura M, Castro MSA (1978) The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 16: 31–7

    Article  PubMed  CAS  Google Scholar 

  18. Fields HL (1987) Pain. New York, McGraw-Hill, p 134

    Google Scholar 

  19. Foley KM (1979) Pain syndromes in patients with cancer. In: Bonica JJ, Ventaffrida V (eds) Advances in pain research and therapy. New York, Raven Press, p 59

    Google Scholar 

  20. Foley KM (1985) The treatment of cancer pain. N Engl J Med 313: 84–95

    Article  PubMed  CAS  Google Scholar 

  21. Fraioli F et al. (1984) Calcitonine and analgesia. In: Benedetti C, Chapman CR, Moricca G (eds) Advances in Pain Research and therapy, vol 7. New York, Raven Press, p 37

    Google Scholar 

  22. Galasko CSB (1981) The development of skeletal metastases. In: Weiss L, Gilbert HA (eds) Bone metastasis. Boston, GK Hall, p 83

    Google Scholar 

  23. Galasko CSB (1986) Skeletal metastases. London, Butterworths, p 22

    Google Scholar 

  24. Galasko CSB (1986) Squeletal Metastases. London, Butterworths, p 99

    Google Scholar 

  25. Galasko CSB (1976) Mechanisms of bone destruction in the development of skeletal metastasis. Nature 263: 507–10

    Article  PubMed  CAS  Google Scholar 

  26. Greenberg HS, Deck MD, Vikram B, Chu FC, Posner JB (1981) Metastasis to the base of the skull: clinical findings in 43 patients. Neurology 31: 530–7

    PubMed  CAS  Google Scholar 

  27. Greenberg HS, Kim J, Posner JB (1980) Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 8: 361–6

    Article  PubMed  CAS  Google Scholar 

  28. Hanks GW (1988) The pharmacological treatment of bone pain. Cancer Surv 7: 87–101

    PubMed  CAS  Google Scholar 

  29. Harpert JC (1987) Radionuclide therapy of bone pain. In: Harpert JC (ed) Nuclear Medicine Therapy. New York, Thieme Medical Publishers Inc, p 208

    Google Scholar 

  30. Hawkey CJ (1999) Cox-2 inhibitors. Lancet 353: 307–14

    Article  PubMed  CAS  Google Scholar 

  31. Hindley AC, Hill AB, Leyland MJ, Wiles AE (1988) A double blind controlled trial of salmon calcotonine in pain due to malignancy. Cancer Chemother Pharmacol 9: 71–4

    Article  Google Scholar 

  32. Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O’keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6: 521–8

    Article  PubMed  CAS  Google Scholar 

  33. Hortobagyi GN, Theriault RL, Porter L et al. (1996) Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 335: 1785–91

    Article  PubMed  CAS  Google Scholar 

  34. Houde RW et al. (1966) Evaluation of analgesics in patients with cancer. In: Lasagna L (ed) International Encyclopedia of pharmacology and therapeutics. New-York, Pergamon Press, p 59

    Google Scholar 

  35. Kelly JB, Payne R (1991) Pain syndromes in the cancer patient. Neurol Clin 4: 937–53

    Google Scholar 

  36. Levick S, Jacob C, Loukas D et al. (1998) Naproxen sodium in treatment of bone pain due to metastatic cancer. Pain 35: 253–8

    Article  Google Scholar 

  37. Maxon HR, Schroder LE, Thomas SR et al. (1990) Re-186(Sn)HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology 175: 155–9

    Google Scholar 

  38. Maxon HR III, Smith HS (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well-diffentiated thyroid cancer. Endocrinol Metab Clin North Am 19: 685–718

    PubMed  Google Scholar 

  39. McCaffery M, Wolff M (1992) Pain relief using cutaneous modalities, positioning and movement. In: Turk DC, Felman CS (eds) Special issue: noninvasive approches to pain management in the terminal ill. New York, Haworth Press, Hospice J, p 121

    Google Scholar 

  40. Patt RB (1993) Classification of cancer pain and cancer pain syndromes. In: Patt RB (ed) Cancer Pain, p 3

    Google Scholar 

  41. Payne R, Janjan N (1998) Management of metastatic bone pain in assessment and treatment of cancer pain. In: Payne R, Patt RB, Hill CS (eds) Progress in Pain Research and Management. IASP Press, Seattle, vol 12, p 269

    Google Scholar 

  42. Portenoy RK (1993) Adjuvant analgesics in pain management. In: Oxford Textbook of Palliative Medicine. Oxford University Press, p 187

    Google Scholar 

  43. Portenoy RK, Lipton RB, Foley KM (1987) Back pain in the cancer patient: an algorithm for evaluation and management. Neurology 37: 134–8

    PubMed  CAS  Google Scholar 

  44. Porter AT, Mertens WC, Stitt L (1993) Strontium-89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship? Am J Clin Oncol 16: 238–42

    Article  PubMed  Google Scholar 

  45. Rawlins MD (1993) Non-opioid analgesics. In: Oxford Textbook of Palliative Medicine. Oxford University Press, p 182

    Google Scholar 

  46. Rodriguez M, Dinapoli RP (1980) Spinal cord compression: with special reference to metastatic epidural tumors. Mayo Clin Proc 55: 442–8

    PubMed  CAS  Google Scholar 

  47. Rosier RN, Hicks DG, Teot LA, Puzas JE, O’Keefe RJ (1998) Mechanisms of bone metastasis. In: Payne R, Patt RB, Hill CS (eds) Assessment and treatment of cancer pain. Progress in Pain Research and Management. IASP Press, Seattle, vol. 12, p 257

    Google Scholar 

  48. Silberstein EB, Elgazzar AH, Kapilivsky A (1992) Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin Nucl Med 22: 17–27

    Article  PubMed  CAS  Google Scholar 

  49. Smith JA (1989) Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-mind, placebo-controlled study. J Urol 141: 85–7

    PubMed  Google Scholar 

  50. Smith JL (1993) Oncologic emergencies. In: Patt RB (ed) Cancer Pain, p 527–41

    Google Scholar 

  51. Symposium Palliative treatment of painfull metastases using radiopharmaceuticals (1992) State of the art, University Hospital Utrecht, Mallinckrodt Nuclear Medicine, May 9, 1992

    Google Scholar 

  52. Thompson SW, Tonge D (2000) Bone cancer gain without the pain. Nat Med 6: 504–5

    Article  PubMed  CAS  Google Scholar 

  53. Turner JH, Claringbold PG, Hetherington EL, Sorby P, Martindale AA (1989) A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol 7: 1926–31

    PubMed  CAS  Google Scholar 

  54. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 234: 231–8

    Google Scholar 

  55. Vecht CHJ, Haaxma-Reiche H, van Putten WLJ, de Visser M, Vries EP, Twijnstra A (1989) Initial bolus of conventional versus high dose dexamethasone in metastatic spinal cord compression. Neurology 39; 1255–7

    PubMed  CAS  Google Scholar 

  56. Wagner G (1984) Frequency of pain in patients with cancer. Recent Results Cancer Res 89: 64–71

    PubMed  CAS  Google Scholar 

  57. Wilner D (1982) Radiology of bone tumors and allied disorders. In: Wilner DM (ed) Cancer metastasis to bone. Philadelphia, WB Saunders, p 3641

    Google Scholar 

  58. Wilson JKV, Masaryk TJ (1989) Neurologic emergencies in the cancer patient. Semin Oncol 16: 494

    Google Scholar 

  59. World Health Organisation (1986) Cancer pain relief. Geneva, World Health Organisation

    Google Scholar 

  60. World Health Organisation (1990) Cancer pain relief and palliative care. World Health Organisation Technical Report, series 804, Geneva, Switzerland, p 7

    Google Scholar 

  61. Santé Canada, Canada, 2005. Rapport du Groupe consultatif d’experts sur l’innocuité des anti-inflammatoires non stéroïdiens (AINS) inhibiteurs sélectifs de la COX2. http://www.hc-sc.gc

  62. Mystakidou K, Katsouda E, Parpa E et al. (2006) Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. Drug Deliv 13(4): 269–76

    Article  PubMed  CAS  Google Scholar 

  63. Coluzzi PH, Schwartzberg L, Conroy JD et al. (2001) Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 91(1–2): 123–30

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Bergonié, 229, cours de l’Argonne, 33076, Bordeaux Cedex

    Fabrice Lakdja (Anesthésiste réanimateur), Florence Dixmerias-Iskandar (Anesthésiste réanimateur) & Laurent Labrèze (Médecin algologue)

Authors
  1. Fabrice Lakdja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florence Dixmerias-Iskandar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laurent Labrèze
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Chirurgie Orthopédique et Réparatrice, Hôpital Pellegrin-Tripode, Place Amélie-Raba-Léon, 33076, Bordeaux Cedex

    Vincent Pointillart

  2. Service d’oncologie médicale, Hôpital Saint-André - CHU Bordeaux, 1, rue Jean Burguet, 33075, Bordeaux Cedex

    Alain Ravaud

  3. Institut Bergonié, 229, cours de l’Argonne, 33076, Bordeaux Cedex

    Jean Palussière

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Lakdja, F., Dixmerias-Iskandar, F., Labrèze, L. (2007). Traitements symptomatiques des douleurs des métastases vertébrales. In: Pointillart, V., Ravaud, A., Palussière, J. (eds) Métastases vertébrales. Springer, Paris. https://doi.org/10.1007/978-2-287-33744-4_35

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-33744-4_35

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-33743-7

  • Online ISBN: 978-2-287-33744-4

Publish with us

Policies and ethics

Search

Navigation